These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model. Wolfe F; Caplan L; Michaud K J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626 [No Abstract] [Full Text] [Related]
3. Early intervention in rheumatoid arthritis. Vasanth LC; Paget SA Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):9-10, 15-7. PubMed ID: 17694189 [No Abstract] [Full Text] [Related]
4. Recommendations for the therapeutics of methotrexate in rheumatoid arthritis. Murphy G; Coughlan R; Devlin J; FitzGerald O; McCarthy G Ir Med J; 2009 Jun; 102(6):170-2. PubMed ID: 19722351 [No Abstract] [Full Text] [Related]
5. In quest of the Holy Grail: efficacy versus effectiveness in rheumatoid arthritis. Fleischmann R J Rheumatol; 2002 Sep; 29(9):2018-9; author reply 2019. PubMed ID: 12233903 [No Abstract] [Full Text] [Related]
7. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature. Peyrin-Biroulet L Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972 [No Abstract] [Full Text] [Related]
17. [Current treatment of rheumatoid arthritis]. Carli P; Landais C; Aletti M; Cournac JM; Poisnel E; Paris JF Rev Med Interne; 2009 Dec; 30(12):1067-79. PubMed ID: 19833415 [TBL] [Abstract][Full Text] [Related]
18. [Cutaneous rash from the use of medicine for rheumatoid arthritis]. Hannuksela M Duodecim; 2006; 122(1):105, 111. PubMed ID: 16509198 [No Abstract] [Full Text] [Related]
19. Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis. Mullan RH; Bresnihan B Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S158-64. PubMed ID: 14969069 [TBL] [Abstract][Full Text] [Related]
20. Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeutics. Aletaha D; Smolen JS Curr Rheumatol Rep; 2003 Dec; 5(6):409-12. PubMed ID: 14609484 [No Abstract] [Full Text] [Related] [Next] [New Search]